Bastone Bronwen
SEC insider (Form 3/4/5 filer). CIK 0001927636. Chief People Officer at Enfusion, Inc. (ENFN). 9 reported Form 4/5 transactions since Sep 2024; latest on Apr 21, 2025. Located in CHICAGO, IL.
Companies Bastone Bronwen has filed insider reports for
- Enfusion, Inc. (ENFN): Officer, Chief People Officer
Bastone Bronwen
CIK: 0001927636
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)4 (44.4%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (22.2%)
Compensation grants
Other (G, F, J, C, D, …)3 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ENFN
Enfusion, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Apr 21, 2025ENFN
Enfusion, Inc.
DispositionDirect15.9K shares- - Apr 21, 2025ENFN
Enfusion, Inc.
DispositionDirect35.3K shares- - Apr 21, 2025ENFN
Enfusion, Inc.
DispositionDirect161.9K shares- - Mar 5, 2025ENFN
Enfusion, Inc.
SaleDirect3.1K shares at avg. $11.38$36K - Mar 3, 2025ENFN
Enfusion, Inc.
SaleDirect2.1K shares at avg. $11.48$24K - Feb 26, 2025ENFN
Enfusion, Inc.
AwardDirect5.7K shares- - Feb 26, 2025ENFN
Enfusion, Inc.
AwardDirect26.5K shares- - Jan 7, 2025ENFN
Enfusion, Inc.
SaleDirect809 shares at avg. $10.13$8K - Sep 10, 2024ENFN
Enfusion, Inc.
SaleDirect3.2K shares at avg. $8.12$26K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 21, 2025 | ENFN Enfusion, Inc. | Disposition | 15,864 | - | - | Direct |
| Apr 21, 2025 | ENFN Enfusion, Inc. | Disposition | 35,294 | - | - | Direct |
| Apr 21, 2025 | ENFN Enfusion, Inc. | Disposition | 161,893 | - | - | Direct |
| Mar 5, 2025 | ENFN Enfusion, Inc. | Sale | 3,126 | $11.38 | $35,558 | Direct |
| Mar 3, 2025 | ENFN Enfusion, Inc. | Sale | 2,064 | $11.48 | $23,697 | Direct |
| Feb 26, 2025 | ENFN Enfusion, Inc. | Award | 5,724 | - | - | Direct |
| Feb 26, 2025 | ENFN Enfusion, Inc. | Award | 26,456 | - | - | Direct |
| Jan 7, 2025 | ENFN Enfusion, Inc. | Sale | 809 | $10.13 | $8,195 | Direct |
| Sep 10, 2024 | ENFN Enfusion, Inc. | Sale | 3,219 | $8.12 | $26,138 | Direct |
1-9 of 9 transactions